High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity
dc.contributor.author | Ringel-Scaia, Veronica M. | en |
dc.contributor.author | Beitel-White, Natalie | en |
dc.contributor.author | Lorenzo, Melvin F. | en |
dc.contributor.author | Brock, Rebecca M. | en |
dc.contributor.author | Huie, Kathleen E. | en |
dc.contributor.author | Coutermarsh-Ott, Sheryl | en |
dc.contributor.author | Eden, Kristin | en |
dc.contributor.author | McDaniel, Dylan K. | en |
dc.contributor.author | Verbridge, Scott S. | en |
dc.contributor.author | Rossmeisl, John H. Jr. | en |
dc.contributor.author | Oestreich, Kenneth J. | en |
dc.contributor.author | Davalos, Rafael V. | en |
dc.contributor.author | Allen, Irving C. | en |
dc.contributor.department | Electrical and Computer Engineering | en |
dc.contributor.department | Biomedical Engineering and Mechanics | en |
dc.contributor.department | Biomedical Sciences and Pathobiology | en |
dc.contributor.department | Small Animal Clinical Sciences | en |
dc.contributor.department | Fralin Biomedical Research Institute | en |
dc.contributor.department | Institute for Critical Technology and Applied Sciences | en |
dc.contributor.department | Virginia Tech Carilion School of Medicine | en |
dc.date.accessioned | 2019-10-02T17:27:36Z | en |
dc.date.available | 2019-10-02T17:27:36Z | en |
dc.date.issued | 2019-06 | en |
dc.description.abstract | Background: Despite promising treatments for breast cancer, mortality rates remain high and treatments for metastatic disease are limited. High-frequency irreversible electroporation (H-FIRE) is a novel tumor ablation technique that utilizes high-frequency bipolar electric pulses to destabilize cancer cell membranes and induce cell death. However, there is currently a paucity of data pertaining to immune system activation following H-FIRE and other electroporation based tumor ablation techniques. Methods: Here, we utilized the mouse 4T1 mammary tumor model to evaluate H-FIRE treatment parameters on cancer progression and immune system activation in vitro and in vivo. Findings: H-FIRE effectively ablates the primary tumor and induces a pro-inflammatory shift in the tumor microenvironment. We further show that local treatment with H-FIRE significantly reduces 4T1 metastases. H-FIRE kills 4T1 cells through non-thermal mechanisms associated with necrosis and pyroptosis resulting in damage associated molecular pattern signaling in vitro and in vivo. Our data indicate that the level of tumor ablation correlates with increased activation of cellular immunity. Likewise, we show that the decrease in metastatic lesions is dependent on the intact immune system and H-FIRE generates 4T1 neoantigens that engage the adaptive immune system to significantly attenuate tumor progression. Interpretation: Cell death and tumor ablation following H-FIRE treatment activates the local innate immune system, which shifts the tumor microenvironment from an anti-inflammatory state to a pro-inflammatory state. The non-thermal damage to the cancer cells and increased innate immune system stimulation improves antigen presentation, resulting in the engagement of the adaptive immune system and improved systemic anti-tumor immunity. (C) 2019 The Authors. Published by Elsevier B.V. | en |
dc.description.notes | This work was supported by the Virginia-Maryland College of Veterinary Medicine (I.C.A.), the Virginia Tech Institute for Critical Technology and Applied Science Center for Engineered Health (I.C.A.), the Virginia Biosciences Health Research Corporation (VBHRC) Catalyst (R.V.D.), and the National Institutes of Health R01CA213423 (R.V.D. and S.S.V.), P01CA207206 (R.V.D and R.V.D.), R56AI127800 (K.J.O.), and R01AI134972 (K.J.O.). Student work on this publication was supported by the National Institute of Allergy and Infectious Diseases Animal Model Research for Veterinarians (AMRV) training grant (T32-OD010430) (S.C.O. and K.E.) and the American Association of Immunologist Careers in Immunology Fellowship Program (V.M.R.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or any other funding agency. | en |
dc.description.sponsorship | Virginia-Maryland College of Veterinary Medicine; Virginia Tech Institute for Critical Technology and Applied Science Center for Engineered Health; Virginia Biosciences Health Research Corporation (VBHRC) Catalyst; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01CA213423, P01CA207206, R56AI127800, R01AI134972]; National Institute of Allergy and Infectious Diseases Animal Model Research for Veterinarians (AMRV) training grant [T32-OD010430]; American Association of Immunologist Careers in Immunology Fellowship Program | en |
dc.description.version | Published version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.doi | https://doi.org/10.1016/j.ebiom.2019.05.036 | en |
dc.identifier.issn | 2352-3964 | en |
dc.identifier.pmid | 31130474 | en |
dc.identifier.uri | http://hdl.handle.net/10919/94322 | en |
dc.identifier.volume | 44 | en |
dc.language.iso | en | en |
dc.rights | Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en |
dc.subject | IRE | en |
dc.subject | Breast cancer | en |
dc.subject | Metastasis | en |
dc.subject | Tumor microenvironment | en |
dc.subject | Pyroptosis | en |
dc.title | High-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity | en |
dc.title.serial | EBioMedicine | en |
dc.type | Article - Refereed | en |
dc.type.dcmitype | Text | en |
dc.type.dcmitype | StillImage | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 1-s2.0-S2352396419303445.pdf
- Size:
- 5.27 MB
- Format:
- Adobe Portable Document Format
- Description:
Collections
Scholarly Works, Biomedical Sciences and Pathobiology
Scholarly Works, Biomedical Engineering and Mechanics
Scholarly Works, Electrical and Computer Engineering
Scholarly Works, Fralin Biomedical Research Institute at VTC
Scholarly Works, Institute for Critical Technology and Applied Science (ICTAS)
Scholarly Works, Small Animal Clinical Sciences
Load more Scholarly Works, Biomedical Engineering and Mechanics
Scholarly Works, Electrical and Computer Engineering
Scholarly Works, Fralin Biomedical Research Institute at VTC
Scholarly Works, Institute for Critical Technology and Applied Science (ICTAS)
Scholarly Works, Small Animal Clinical Sciences